Brief: Cyclopharm Says Inspection Of Kingsgrove By US FDA Will Be Conducted Between July Through Aug
09/05/2023 02:24
May 9 (Reuters) - Cyclopharm CYC.AX :
* INSPECTION OF CO'S KINGSGROVE, NEW SOUTH WALES FACILITY BY
US
FDA WILL BE CONDUCTED BETWEEN 24 JULY THROUGH 4 AUGUST 2023
Source text for Eikon: ID:nASX6SDrC4
Further company coverage: CYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair